Skip to Content

COVID-19 Linked to Increased All-Cause Mortality in Young Adults

WEDNESDAY, Dec. 16, 2020 -- From March to July 2020, the COVID-19 pandemic was associated with increased all-cause mortality among 25- to 44-year-olds in the United States, according to a research letter published online Dec. 16 in the Journal of the American Medical Association.

Jeremy Samuel Faust, M.D., from Brigham and Women's Hospital in Boston, and colleagues examined excess mortality by calculating projected monthly expected deaths for 2020. All-cause and COVID-19 mortality were obtained for March 1, 2020, to July 31, 2020; COVID-19 deaths were compared to unintentional opioid deaths in 2018.

The researchers found that among U.S. adults aged 25 to 44 years, there were 76,088 all-cause deaths from March 1 to July 31, 2020, which was 11,899 more than the expected 64,189 deaths (incident rate ratio, 1.19). Nationally and overall in every U.S. Department of Health and Human Services region, excess mortality occurred in every month of the study period. There were 4,535 COVID-19 deaths recorded nationally among adults aged 25 to 44 years, accounting for 38 percent of the excess mortality. In three HHS regions, deaths due to COVID-19 exceeded 2018 unintentional opioid deaths during one month in 2020.

"In some regions that experienced substantial COVID-19 surges, COVID-19 deaths among U.S. adults ages 25 to 44 equaled or exceeded the number of deaths caused by unintentional opioid overdoses in 2018," Faust said in a statement. "In these regions, COVID-19 appears to have temporarily rivalled or surpassed the usual leading cause of death among U.S. adults ages 25 to 44."

One author disclosed financial ties to the health care, legal, and technology industries.

Abstract/Full Text

© 2021 HealthDay. All rights reserved.

Posted: December 2020

Read this next

Bamlanivimab + Etesevimab Reduces SARS-CoV-2 Viral Load

FRIDAY, Jan. 22, 2021 -- Treatment with bamlanivimab and etesevimab, but not monotherapy with bamlanivimab, is associated with a reduction in severe acute respiratory syndrome...

Total Pediatric ED Visits Decreased in 2020 Versus 2018, 2019

FRIDAY, Jan. 22, 2021 -- There was a decrease in the total number of pediatric emergency department visits in 2020, but the proportion of trauma-related visits increased,...

Tocilizumab Does Not Improve Outcomes in Severe COVID-19

THURSDAY, Jan. 21, 2021 -- Tocilizumab plus standard care is not superior to standard care alone for improving clinical outcomes among patients with severe or critical COVID-19...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.